Publisher
Springer Science and Business Media LLC
Reference130 articles.
1. Wang, Q., Peng, H., Qi, X., Wu, M. & Zhao, X. (2020). Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence. Signal Transduction and Targeted Therapy, 5(1), 137.
2. Li, S., Shen, H., Wan, Q., Chen, P., Shu, C., & Wang, H., et al. (2023). Downregulation of HS6ST2 inhibits cervical cancer cell migration and invasion in vivo and in vitro. Discovery Medicine, 35(179), 1147–1159.
3. Zhao, C., Tang, X., Chen, X., & Jiang, Z. (2024). Multifaceted carbonized metal–organic frameworks synergize with immune checkpoint inhibitors for precision and augmented cuproptosis cancer therapy. ACS Nano, 18(27), 17852–17868.
4. Keyvani, V., Riahi, E., Yousefi, M., Esmaeili, S. A., Shafabakhsh, R. & Moradi Hasan-Abad, A. et al. (2022). Gynecologic cancer, cancer stem cells, and possible targeted therapies. Frontiers in Pharmacology, 13, 823572.
5. Wei, H., Zhang, Y., Jia, Y., Chen, X., Niu, T., & Chatterjee, A., et al. (2024). Heat shock protein 90: Biological functions, diseases, and therapeutic targets. MedComm (2020), 5(2), e470.